As for mortality, highly significant improvements were registered among all age classes, with more favorable trends for younger patients.
← all excerpts
The national and subnational burden of Hodgkin Lymphoma (HL) in Italy from 1990 to 2023: results from the Global Burden of Disease Study 2023.
1
—
—